ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för rifampicin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

36 träffar

Bibliografisk träff 2017-11-01

Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis.

Chen S, Han Y, Yu D, Huo F, Wang F, Li Y, Dong L, Liu Z, Huang H.

Drug Deliv · comparative study; research-article; journal article · DOI 10.1080/10717544.2016.1267275

Bibliografisk träff 2017-03-06

A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.

Giddey AD, de Kock E, Nakedi KC, Garnett S, Nel AJ, Soares NC, Blackburn JM.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/srep43858

Bibliografisk träff 2017-02-01

Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.

He L, Guo Y, Deng Y, Li C, Zuo C, Peng W.

Xenobiotica · journal article · DOI 10.3109/00498254.2016.1160159

Bibliografisk träff 2017-02-01

Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.

Chen G, He JQ.

Medicine (Baltimore) · journal article; case reports; case-report · DOI 10.1097/md.0000000000006135

Bibliografisk träff 2017-01-27

Silver-loaded nanotubular structures enhanced bactericidal efficiency of antibiotics with synergistic effect in vitro and in vivo.

Xu N, Cheng H, Xu J, Li F, Gao B, Li Z, Gao C, Huo K, Fu J, Xiong W.

Int J Nanomedicine · research-article; journal article · DOI 10.2147/ijn.s123648

Bibliografisk träff 2017-01-12

Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.

Xia H, Zheng Y, Zhao B, van den Hof S, Cobelens F, Zhao Y.

PLoS One · research-article; evaluation study; journal article · DOI 10.1371/journal.pone.0169413

Bibliografisk träff 2016-12-01

Diagnosis of Pulmonary Tuberculosis and Detection of Resistance to Rifampin and Isoniazid through Direct Molecular Methods in Stool Samples.

Yousef SA, AbdelRahim KA, Ahmed AO, Almaary KS, Mohamed AM.

Ann Clin Lab Sci · journal article

Bibliografisk träff 2016-11-29

Rifampicin Attenuated Global Cerebral Ischemia Injury via Activating the Nuclear Factor Erythroid 2-Related Factor Pathway.

Chen B, Cao H, Chen L, Yang X, Tian X, Li R, Cheng O.

Front Cell Neurosci · research-article; journal article · DOI 10.3389/fncel.2016.00273

Bibliografisk träff 2016-11-22

[First clinical isolate of Mycobacterium tuberculosis exhibiting resistance to rifampicin and sensibility to isoniazid in the Elche´s Health Department-General Hospital(1998-2015)].

Ruiz-García MM, Grau Delgado J, Andrés Franch MI, Prats Sánchez I.

Rev Esp Quimioter · letter; case reports

Bibliografisk träff 2016-10-18

Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice.

Chauffour A, Robert J, Veziris N, Aubry A, Jarlier V.

PLoS Negl Trop Dis · research-article; journal article · DOI 10.1371/journal.pntd.0005066

Bibliografisk träff 2016-10-01

Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature.

Ji G, Zeng X, Sandford AJ, He JQ.

Int J Clin Pharmacol Ther · review; journal article; case reports · DOI 10.5414/cp202576

Bibliografisk träff 2016-09-01

[An experimental study on a slow-release complex with rifampicin-polylactic-co-glycolic acid-calcium  phosphate cement].

Wu J, Ding Z, Lei Q, Li M, Liang Y, Lu T.

Zhong Nan Da Xue Xue Bao Yi Xue Ban · journal article · DOI 10.11817/j.issn.1672-7347.2016.09.009

Bibliografisk träff 2016-09-01

Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact.

Agrawal A, Agarwal SK, Kaleekal T, Gupta YK.

Indian J Nephrol · research-article; journal article · DOI 10.4103/0971-4065.176145

Bibliografisk träff 2016-07-26

Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway.

Zhang W, Chen L, Shen Y, Xu J.

Toxicol In Vitro · journal article · DOI 10.1016/j.tiv.2016.07.017

Bibliografisk träff 2016-06-15

Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.

Scheinfeld N.

Dermatol Online J · review; journal article · DOI 10.5070/d3226031313

Bibliografisk träff 2016-05-12

Integrated therapy for HIV and tuberculosis.

Manosuthi W, Wiboonchutikul S, Sungkanuparph S.

AIDS Res Ther · review-article; review; journal article · DOI 10.1186/s12981-016-0106-y

Bibliografisk träff 2016-05-01

[Application of Gene Xpert Mycobacterium tuberculosis DNA and resistance to rifampicin assay in the rapid detection of tuberculosis in children].

Zhang AM, Li F, Liu XH, Xia L, Lu SH.

Zhonghua Er Ke Za Zhi · journal article · DOI 10.3760/cma.j.issn.0578-1310.2016.05.012

Bibliografisk träff 2016-04-01

Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.

He XC, Zhang XX, Zhao JN, Liu Y, Yu CB, Yang GR, Li HC.

Medicine (Baltimore) · research support, non-u.s. gov't; research-article; journal article; observational study · DOI 10.1097/md.0000000000003336

Bibliografisk träff 2016-02-17

Genotyping of mutations detected with GeneXpert.

N'guessan Kouassi K, Riccardo A, Dutoziet Christian C, André G, Férilaha C, Hortense SA, Jean-Marc A, Daniela Maria C, Mireille D.

Int J Mycobacteriol · journal article · DOI 10.1016/j.ijmyco.2016.01.001

Bibliografisk träff 2016-01-01

Influence of Food on Rifampicin Pharmacokinetics in Rats.

Shimomura H, Nogami R, Shigeno A, Shimada S, Aoyama T.

Biol Pharm Bull · journal article · DOI 10.1248/bpb.b15-00445

Bibliografisk träff 2015-11-14

Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes.

Shimomura H, Andachi S, Aono T, Kigure A, Yamamoto Y, Miyajima A, Hirota T, Imanaka K, Majima T, Masuyama H, Tatsumi K, Aoyama T.

J Pharm Health Care Sci · research-article; journal article · DOI 10.1186/s40780-015-0029-0

Bibliografisk träff 2015-02-26

Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans.

Golegaonkar S, Tabrez SS, Pandit A, Sethurathinam S, Jagadeeshaprasad MG, Bansode S, Sampathkumar SG, Kulkarni MJ, Mukhopadhyay A.

Aging Cell · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/acel.12327

Bibliografisk träff 2014-01-01

[Validation of a liquid chromatography method for rifampicin determination in human plasma].

Moreno-Exebio L, Grande-Ortiz M.

Rev Peru Med Exp Salud Publica · research support, non-u.s. gov't; validation study; journal article · DOI 10.17843/rpmesp.2014.311.8

Bibliografisk träff 2009-09-01

Rifampicin serum levels in childhood tuberculosis.

Thee S, Detjen A, Wahn U, Magdorf K.

Int J Tuberc Lung Dis · journal article

Bibliografisk träff 2009-05-19

Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.

Shichiri M, Fukai N, Kono Y, Tanaka Y.

Cancer Res · research support, non-u.s. gov't; evaluation study; journal article · DOI 10.1158/0008-5472.can-08-3417

Bibliografisk träff 2009-04-22

Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis.

Schaaf HS, Willemse M, Cilliers K, Labadarios D, Maritz JS, Hussey GD, McIlleron H, Smith P, Donald PR.

BMC Med · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1741-7015-7-19

Bibliografisk träff 2008-03-10

Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells.

Haslam IS, Jones K, Coleman T, Simmons NL.

Br J Pharmacol · other; research support, non-u.s. gov't; journal article · DOI 10.1038/bjp.2008.69

Bibliografisk träff 2007-11-01

The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.

Baldan HM, De Rosa HJ, Brunetti IL, Ximenes VF, Machado RG.

Biopharm Drug Dispos · research support, non-u.s. gov't; journal article · DOI 10.1002/bdd.570

Bibliografisk träff 2006-03-03

Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.

Oida Y, Kitaichi K, Nakayama H, Ito Y, Fujimoto Y, Shimazawa M, Nagai H, Hara H.

Brain Res · comparative study; journal article · DOI 10.1016/j.brainres.2006.01.116

Bibliografisk träff 2005-02-10

Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin.

Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR.

Mol Endocrinol · research support, u.s. gov't, p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1210/me.2004-0346